RCKT — Rocket Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapSucker Stock

Annual balance sheet for Rocket Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	483	389	356	373	372
Prepaid Expenses
Total Current Assets	487	392	364	378	378
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	70.6	72.3	77.6	87.6	83.3
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	591	497	552	566	528
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	32.6	22.2	39.2	48.5	40.7
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	87.3	42.3	62.1	73.8	64.5
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	504	455	490	493	463
Total Liabilities & Shareholders' Equity	591	497	552	566	528
Total Common Shares Outstanding